Aberrant Schwann Cell Lipid Metabolism Linked to Mitochondrial Deficits Leads to Axon Degeneration and Neuropathy

被引:193
作者
Viader, Andreu [1 ]
Sasaki, Yo [1 ]
Kim, Sungsu [1 ]
Strickland, Amy [1 ]
Workman, Cayce S. [1 ]
Yang, Kui [2 ]
Gross, Richard W. [2 ]
Milbrandt, Jeffrey [1 ,3 ]
机构
[1] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
MULTIDIMENSIONAL MASS-SPECTROMETRY; LONG-CHAIN ACYLCARNITINE; TRANSCRIPTION FACTOR; STRESS; MYELIN; IDENTIFICATION; ACID; MICE; MOLECULES;
D O I
10.1016/j.neuron.2013.01.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mitochondrial dysfunction is a common cause of peripheral neuropathy. Much effort has been devoted to examining the role played by neuronal/axonal mitochondria, but how mitochondrial deficits in peripheral nerve glia (Schwann cells [SCs]) contribute to peripheral nerve diseases remains unclear. Here, we investigate a mouse model of peripheral neuropathy secondary to SC mitochondria! dysfunction (Tfam-SCKOs). We show that disruption of SC mitochondria activates a maladaptive integrated stress response (ISR) through the actions of heme-regulated inhibitor (H RI) kinase, and causes a shift in lipid metabolism away from fatty acid synthesis toward oxidation. These alterations in SC lipid metabolism result in depletion of important myelin lipid components as well as in accumulation of acylcarnitines (ACs), an intermediate of fatty acid beta-oxidation. Importantly, we show that ACs are released from SCs and induce axonal degeneration. A maladaptive ISR as well as altered SC lipid metabolism are thus underlying pathological mechanisms in mitochondria-related peripheral neuropathies.
引用
收藏
页码:886 / 898
页数:13
相关论文
共 40 条
  • [1] Atkinson D.E., 1968, NEUROSCIENTIST, V7, P4030
  • [2] Structure and regulation of acetyl-CoA carboxylase genes of metazoa
    Barber, MC
    Price, NT
    Travers, MT
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2005, 1733 (01): : 1 - 28
  • [3] The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
    Barres, Ben A.
    [J]. NEURON, 2008, 60 (03) : 430 - 440
  • [4] Neuron-astrocyte interactions: Partnership for normal function and disease in the central nervous system
    Benarroch, EE
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (10) : 1326 - 1338
  • [5] Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models
    Chrast, Roman
    Saher, Gesine
    Nave, Klaus-Armin
    Verheijen, Mark H. G.
    [J]. JOURNAL OF LIPID RESEARCH, 2011, 52 (03) : 419 - 434
  • [6] Phosphoproteins in Stress-Induced Disease
    Dalton, Lucy E.
    Healey, Eleanor
    Irving, James
    Marciniak, Stefan J.
    [J]. PROTEIN PHOSPHORYLATION IN HEALTH AND DISEASE, 2012, 106 : 189 - 221
  • [7] Myelin abnormalities in mice deficient in galactocerebroside and sulfatide
    Dupree, JL
    Coetzee, T
    Suzuki, K
    Popko, B
    [J]. JOURNAL OF NEUROCYTOLOGY, 1998, 27 (09): : 649 - 659
  • [8] Mitochondrial transcription factor A regulates mtDNA copy number in mammals
    Ekstrand, MI
    Falkenberg, M
    Rantanen, A
    Park, CB
    Gaspari, M
    Hultenby, K
    Rustin, P
    Gustafsson, CM
    Larsson, NG
    [J]. HUMAN MOLECULAR GENETICS, 2004, 13 (09) : 935 - 944
  • [9] P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells
    Feltri, ML
    D'Antonio, M
    Previtali, S
    Fasolini, M
    Messing, A
    Wrabetz, L
    [J]. CHARCOT-MARIE-TOOTH DISORDERS, 1999, 883 : 116 - 123
  • [10] Fernyhough Paul, 2010, Expert Rev Endocrinol Metab, V5, P39